Atea Pharmaceuticals, Inc.

AVIR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.61-1.91%

2026-08-03

Financials

Valuation Metrics

Atea Pharmaceuticals, Inc.'s Market Cap is $369M. At end of 2025 it was $279M. Ranked #2912 of 3,112 in US market (top 94%), #1293 of 1,445 on NASDAQ (top 89%), #235 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 87%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$369M	US#2,912/3,112 Sec#235/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-170M	US—/3,112 Sec—/269
Total Assets	$267M	US#2,928/3,112 Sec#226/269
Net Assets	$234M	US#2,676/3,112 Sec#182/269
Value
P/B	1.58x	US#885/3,112 Sec#39/269
FCF Yield	-40.08%	US—/3,112 Sec—/269
Profitability
ROE	-72.53%	US#2,811/3,112 Sec#204/269
ROA	-63.47%	US#3,011/3,112 Sec#242/269
Financial Health
Debt Ratio	14.28%	US#168/3,112 Sec#70/269
Total Debt	$634000.00	US#2,945/3,112 Sec#254/269
FCF	$-148M	US#2,676/3,112 Sec#188/269
Cash	$79M	US#2,343/3,112 Sec#190/269
Current Ratio	7.89x	US#305/3,112 Sec#98/269
Performance
1Y Return	32.85%	US#1,186/3,112 Sec#142/269
1M Return	-7.43%	US#2,444/3,112 Sec#144/269
From 52W High	-28.53%	US#2,108/3,112 Sec#156/269
1Y MDD	-33.33%	US#1,596/3,112 Sec#102/269
Trading
Volume	222,095 shares	US#2,595/3,112 Sec#249/269
Trading Value	$1M	US#3,020/3,112 Sec#256/269
Per Share
EPS	$-2.03	US—/3,112 Sec—/269
BPS	$3.53	US#2,368/3,112 Sec#154/269